As summarized in Fig. 8, Fyn was activated in HSCs with TGF-β stimulation, chronic CCl4 treated fibrotic mouse liver, and liver samples from human liver fibrosis patients. This evidence concerns the gene TGFB1 and Hepatic fibrosis.